Blogs

Jun 21, 2018
Applied Clinical Trials
How much does the EU really care about health, and about the infrastructure that is a precondition to successful healthcare and healthcare innovation?
Jun 18, 2018
Applied Clinical Trials
In this article, Moe will demonstrate a methodology that resulted in improving CRA performance.
Jun 18, 2018
Applied Clinical Trials
The right-to-try gale is now blowing at full strength in the US and is likely to prove a straw in the wind that could become a haystack.
Jun 13, 2018
Applied Clinical Trials
Liquid biopsy, typically non-invasive blood-based tests for circulating tumor DNA and circulating tumor cells, has been long-hyped as a potential game-changer for cancer treatment.
Jun 06, 2018
Applied Clinical Trials
To manage the growing scope and complexity of global disclosure regulations and trial transparency initiatives, companies are advised to create a cross-functional clinical transparency committee.
Jun 06, 2018
Applied Clinical Trials
In this article, we will discuss trends and challenges with medical monitoring clinical analytics, analyze the alignment of existing medical monitoring tools and technologies with ICH-E6 (R2) addendum guidelines, and discuss trends in medical monitoring insourcing and outsourcing models.
Jun 01, 2018
Applied Clinical Trials
Peter O’Donnell explores the convergence of policy and science in new vaccine R&D pursuits in Europe.
Jun 01, 2018
Applied Clinical Trials
Editor-in-Chief Lisa Henderson speak about therapeutic needs, rare diseases in children, and the SCORR Marketing survey on innovative or flexible trial designs.
Jun 01, 2018
Applied Clinical Trials
During an audit, the FDA investigates six areas to determine whether a site is in compliance with federal drug accountability regulations.
May 31, 2018
Applied Clinical Trials
Peter O'Donnell discusses the EU's bid to improve the HTA and weighs in on a report made by Soledad Cabezón.
native1_300x100
lorem ipsum